BONUCCELLI, UBALDO
 Distribuzione geografica
Continente #
NA - Nord America 35.147
AS - Asia 14.354
EU - Europa 12.928
SA - Sud America 2.027
AF - Africa 606
OC - Oceania 84
Continente sconosciuto - Info sul continente non disponibili 13
Totale 65.159
Nazione #
US - Stati Uniti d'America 34.220
IT - Italia 4.789
CN - Cina 4.454
SG - Singapore 4.445
HK - Hong Kong 2.721
SE - Svezia 1.944
BR - Brasile 1.755
DE - Germania 1.260
BG - Bulgaria 1.197
CA - Canada 812
VN - Vietnam 747
GB - Regno Unito 742
TR - Turchia 637
RU - Federazione Russa 596
UA - Ucraina 566
FI - Finlandia 560
KR - Corea 518
AT - Austria 320
IN - India 257
CH - Svizzera 233
FR - Francia 216
CI - Costa d'Avorio 202
NG - Nigeria 142
PL - Polonia 102
NL - Olanda 95
AR - Argentina 94
BD - Bangladesh 83
JP - Giappone 79
SN - Senegal 74
ZA - Sudafrica 73
BE - Belgio 70
MX - Messico 68
AU - Australia 67
IQ - Iraq 58
ES - Italia 53
ID - Indonesia 42
EC - Ecuador 39
CO - Colombia 35
SA - Arabia Saudita 33
PK - Pakistan 32
MA - Marocco 31
VE - Venezuela 30
CZ - Repubblica Ceca 29
IL - Israele 26
UZ - Uzbekistan 26
LT - Lituania 25
IE - Irlanda 22
TW - Taiwan 22
EG - Egitto 21
JO - Giordania 21
PE - Perù 20
PY - Paraguay 20
KE - Kenya 19
GR - Grecia 18
IR - Iran 17
NZ - Nuova Zelanda 17
AE - Emirati Arabi Uniti 15
CL - Cile 13
MY - Malesia 13
AZ - Azerbaigian 12
RO - Romania 12
OM - Oman 11
BJ - Benin 10
EU - Europa 10
PH - Filippine 10
TN - Tunisia 10
BO - Bolivia 9
HU - Ungheria 9
PT - Portogallo 9
UY - Uruguay 9
AM - Armenia 8
DK - Danimarca 8
JM - Giamaica 8
NP - Nepal 8
DZ - Algeria 7
HN - Honduras 7
LB - Libano 7
RS - Serbia 7
TT - Trinidad e Tobago 7
AL - Albania 6
EE - Estonia 6
GE - Georgia 6
HR - Croazia 6
KG - Kirghizistan 6
BN - Brunei Darussalam 5
CR - Costa Rica 5
KZ - Kazakistan 5
PA - Panama 5
BY - Bielorussia 4
LK - Sri Lanka 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
KH - Cambogia 3
KW - Kuwait 3
ME - Montenegro 3
NO - Norvegia 3
Totale 65.104
Città #
Woodbridge 4.155
Ashburn 3.590
Fairfield 3.473
Ann Arbor 2.740
Hong Kong 2.692
Houston 2.593
Singapore 2.288
Chandler 2.014
Seattle 1.466
Dallas 1.437
Serra 1.288
Santa Clara 1.267
Cambridge 1.225
Sofia 1.190
Wilmington 1.179
Milan 982
Beijing 926
Shanghai 898
New York 801
Jacksonville 781
Ottawa 691
Hefei 654
Boardman 527
Princeton 526
Seoul 493
Lawrence 462
Medford 437
Izmir 371
Los Angeles 370
Nanjing 355
Des Moines 313
Vienna 284
Dearborn 242
Florence 224
Istanbul 214
Bern 213
Abidjan 202
Dong Ket 192
Buffalo 190
Frankfurt am Main 186
Pisa 176
Munich 175
Nanchang 158
San Diego 151
Jüchen 145
Lagos 142
Redwood City 140
Redondo Beach 139
São Paulo 136
Lancaster 128
London 124
Rome 121
Ho Chi Minh City 114
Kunming 101
Bremen 90
Norwalk 83
Shenyang 80
Turku 79
Ogden 75
Dakar 74
Warsaw 72
Pune 65
Tokyo 65
Boulder 63
Changsha 63
Hebei 62
Brussels 60
Council Bluffs 60
Belo Horizonte 59
Guangzhou 59
San Jose 56
Columbus 55
The Dalles 54
Chicago 53
Tianjin 49
Hanoi 46
Düsseldorf 44
Jiaxing 44
Phoenix 44
Lucca 42
Rio de Janeiro 42
Fuzhou 40
Nuremberg 39
Brooklyn 38
Washington 37
Johannesburg 35
Hangzhou 33
Helsinki 31
Montreal 31
Porto Alegre 31
Melbourne 30
Baghdad 29
Quanzhou 29
San Francisco 28
Guarulhos 27
Brasília 26
Toronto 26
Auburn Hills 25
Boston 24
Cascina 24
Totale 48.302
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 513
Actigraphic sleep detection: an artificial intelligence approach 351
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 309
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 274
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 260
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 259
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 249
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 245
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 242
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 238
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 233
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 231
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 224
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 219
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 218
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 218
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 218
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 215
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 212
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 209
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 209
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 209
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 204
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 203
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 202
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 202
Thyroid function and oral TRH in amyotrophic lateral sclerosis 201
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 200
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 200
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 199
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 199
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 196
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 195
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 194
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 194
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 194
A case of pelvic floor myoclonic jerk syndrome. 193
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 192
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 192
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 188
Postpartum headache due to spontaneous cervical artery dissection 186
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 186
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 186
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 185
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 184
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 184
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 184
Reduced luteinizing hormone secretion in women with Parkinson's disease 183
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 183
Activity-based diary for Parkinson's disease, 182
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 182
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 182
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 181
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 181
A case of sarcoidosis presenting as a non-specific intramedullary lesion 179
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 177
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 176
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 176
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 176
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 176
Antipsychotic drugs in Huntington's disease 176
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 175
What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer's Disease Degeneration 174
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 174
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 174
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 173
Acute and chronic effects of clozapine in essential tremor 173
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 173
Effect of metadoxine on striatal dopamine levels in C57 black mice 172
COMPARISON OF THE EFFECTS OF BARBEXACLONE AND PHENOBARBITAL ON EPILEPTIC PATIENTS 171
A whole-brain analysis in de novo Parkinson disease 171
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 171
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 171
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 171
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 170
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 170
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 170
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports 169
Dopamine agonists in the treatment of Parkinson's disease 169
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia 169
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 169
Non-rapid eye movement sleep instability in fronto-temporal dementia 169
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 169
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 167
Levodopa in the treatment of Parkinson's disease: current controversies 167
Depressive symptoms in Parkinson's disease 167
NREM sleep transient events in fronto-temporal dementia: beyond sleep stage architecture 167
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 167
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 166
A case of comorbidity between multiple sclerosis and multiple system atrophy 166
Prefrontal cortex, dopamine, and jealousy endophenotype. 166
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 166
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 165
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 165
Effect of lacosamide on sleep-wake cycle of adult patients with drug-resistant partial onset epilepsy 165
Localized calcific hematoma of the scalp presenting as a nummular-like headache: a case report. 165
SUNA syndrome with seasonal pattern 164
Role of dopamine agonists in Parkinson's disease: an update 163
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders 163
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation 163
Totale 19.487
Categoria #
all - tutte 174.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.234 0 0 0 0 0 0 301 364 372 348 244 605
2021/20224.925 85 206 101 328 992 673 97 273 338 142 262 1.428
2022/20236.192 756 746 418 522 822 832 56 465 1.012 35 438 90
2023/20244.627 637 501 562 277 621 884 182 185 80 82 197 419
2024/202512.794 56 531 145 717 957 1.140 1.017 724 1.404 1.933 1.586 2.584
2025/20268.692 978 2.061 1.726 1.161 1.372 1.385 9 0 0 0 0 0
Totale 65.925